Serina Therapeutics, Inc.
SER · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$11,207 | $5,269 | -$2,682 | -$1,265 |
| Dep. & Amort. | $194 | $90 | $61 | $33 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $2,595 | $25 | $7 | $83 |
| Change in WC | -$3,316 | $81 | -$12 | -$755 |
| Other Non-Cash | -$5,403 | -$7,941 | $550 | -$348 |
| Operating Cash Flow | -$17,137 | -$2,476 | -$2,076 | -$2,251 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$22 | -$504 | -$10 | -$108 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $991 | $932 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$22 | -$504 | $981 | $823 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $2,875 | $10,052 | $1,308 | -$13 |
| Stock Issued | $5,000 | $15 | $4 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $5,337 | $0 | $0 | $1,090 |
| Financing Cash Flow | $13,212 | $10,067 | $1,312 | $1,077 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$3,947 | $7,087 | $217 | -$350 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $7,619 | $532 | $315 | $665 |
| End Cash | $3,672 | $7,619 | $532 | $315 |
| Free Cash Flow | -$17,159 | -$2,980 | -$2,085 | -$2,359 |